Moses Jennifer K. is CFO of G1 Therapeutics Inc.
Person profile
Roles
Address
Research Triangle Park, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Viridian Therapeutics, Inc.\DE
28 Jun 24
4
Viridian Therapeutics, Inc.\DE
16 Jun 23
4
G1 Therapeutics, Inc.
5 Jan 23
4
Viridian Therapeutics, Inc.\DE
10 Jun 22
4
G1 Therapeutics, Inc.
2 Feb 22
4
G1 Therapeutics, Inc.
5 Jan 22
4
Viridian Therapeutics, Inc.\DE
15 Jul 21
3
Viridian Therapeutics, Inc.\DE
15 Jul 21
4
G1 Therapeutics, Inc.
4 Mar 21
4
G1 Therapeutics, Inc.
5 Jan 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Jun 24 | VRDN Viridian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 12.31 | 21,000 | 258.51 k | 21,000 |
14 Jun 23 | VRDN Viridian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 27.67 | 20,000 | 553.40 k | 20,000 |
5 Jan 23 | GTHX G1 Therapeutics | Common Stock | Sell | Dispose S | No | No | 5.4075 | 729 | 3.94 k | 57,820 |
4 Jan 23 | GTHX G1 Therapeutics | Common Stock | Sell | Dispose S | No | No | 5.5756 | 1,639 | 9.14 k | 58,549 |
3 Jan 23 | GTHX G1 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 22,300 | 0.00 | 60,188 |
3 Jan 23 | GTHX G1 Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 5.73 | 44,600 | 255.56 k | 44,600 |